Strongbridge Biopharma

$2.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+2.99%) Today
-$0.02 (-0.73%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell SBBP and other stocks, options, and ETFs commission-free!

About SBBP

Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded on May 26, 2015 and is headquartered in Trevose, PA. The listed name for SBBP is Strongbridge Biopharma plc Ordinary Shares.

CEO
John H. Johnson
Employees
71
Headquarters
Trevose, Pennsylvania
Founded
2015
Market Cap
185.59M
Price-Earnings Ratio
Dividend Yield
Average Volume
479.46K
High Today
$2.77
Low Today
$2.65
Open Price
$2.65
Volume
138.32K
52 Week High
$4.63
52 Week Low
$1.50

Collections

SBBP Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 23

You May Also Like